Prognosis of DLCL patients is variable and associated with well-deยฎned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation
Prognostic indicators in diffuse large-cell (histiocytic) lymphoma
โ Scribed by Mary B. Todd; Carol S. Portlock; Leonard R. Farber; Theodore R. Holford; Joseph R. Bertino
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 920 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Diffuse large Bโcell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A
A case of spontaneous remission in a Stage IIA diffuse large cell lymphoma is presented. Review of the literature suggests that whereas spontaneous regressions are a well-recognized phenomenon in indolent lymphomas, it is extremely rare in lymphomas of aggressive histologic subtype.